Legacy Wealth Management (Idaho)’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-29
Closed -$8.49K 410
2026
Q1
$8.49K Buy
29
+13
+81% +$4.27K ﹤0.01% 524
2025
Q4
$5.61K Buy
16
+14
+700% +$4.73K ﹤0.01% 516
2025
Q3
$647 Hold
2
﹤0.01% 665
2025
Q2
$778 Sell
2
-18
-90% -$7.24K ﹤0.01% 613
2025
Q1
$8.7K Hold
20
0.01% 356
2024
Q4
$7.83K Buy
20
+18
+900% +$7.53K 0.01% 325
2024
Q3
$822 Buy
+2
New +$1.07K ﹤0.01% 562

Other funds holding ELV

Legacy Wealth Management (Idaho)'s ELV Position: Q2 2026 in Review

Legacy Wealth Management (Idaho) sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 29 shares — an estimated $8.49K sold.

Legacy Wealth Management (Idaho) first reported a position in ELV in Q3 2024 and held it in 7 quarters. The position peaked at $8.7K in Q1 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Legacy Wealth Management (Idaho) reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
  • Legacy Wealth Management (Idaho) sold 29 Elevance Health shares in Q2 2026, an estimated $8.49K.
  • Legacy Wealth Management (Idaho) first reported a position in Elevance Health in Q3 2024 and held it in 7 quarters.
  • Legacy Wealth Management (Idaho)'s Elevance Health position peaked at $8.7K in Q1 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Legacy Wealth Management (Idaho)'s 13F filing for Q2 2026, filed 13 Aug 2026.